Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)
Clinical trial NCT06744686 · COMPLETED
Trial details
- NCT number
- NCT06744686
- Sponsor
- Suzhou HepaThera Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2024-03-12
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.